Stereotactic
systems are mostly used in minimally invasive surgical
technique for precisely directing the tip of a delicate instrument or
beam of radiation in three-dimensional coordinates to locate target
part inside the body and to perform ablation, biopsy, lesion,
injection, stimulation, implantation, radiosurgery (SRS), and others.
Stereotaxic surgery is mostly used to locate lesions in the brain and
deliver radiation therapy for the treatment of Parkinson’s disease.
During radiation therapy, it is used to focus high-intensity
radiation on targeted areas to shrink tumors. Stereotactic systems
are effective for guiding fine-needle aspiration biopsies of brain
lesions.
For
In-Depth Review | Get Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2424
Stereotactic
Systems Market - Drivers
Rapid
innovation in minimally invasive surgery techniques is one of the
major factors, which is expected to boost growth of the stereotactic
systems market. For instance, in November 2018, Monteris Medical,
published the favorable clinical data for its NeuroBlate Laser
Ablation after Stereotactic Radiosurgery (LAASR) for patients with
brain metastasis in the Journal of Neurosurgery. The NeuroBlate
System is a minimally invasive, robotically controlled laser
thermotherapy that uses MRI-guided laser light to ablate unwanted
tissue in the brain where the lesion originates. Monteris is
exclusively focused on advancing both LITT technology and clinical
research to serve the unmet needs of neurosurgeons and their
patients.
Stereotactic
Systems Market - Regional Analysis
On
the basis of region, the global stereotactic systems market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
Based
on region, North America is projected to gain major share in the
stereotactic systems market, owing to expansion of various key
players in this region. For instance, in March 2016, Monteris
Medical, a privately held company, started developing innovative
laser-based MRI-guided neuroablation tools and solutions in its new
facility unit in Plymouth, Minnesota. Moreover, increasing prevalence
of Parkinson's disease (PD) creates demand for stereotactic systems
for treating the disease, which will in turn boost growth of the
market. For instance, in March 2018, the Parkinson’s Foundation
Prevalence Project estimated that about 60,000 Americans are
diagnosed with PD each year. This number is predicted to rise to 1.2
million in upcoming years. The combined cost of Parkinson’s
disease, including treatment, social security payments, and lost
income from inability to work, is estimated to be nearly US$ 25 bn
per year in the U.S. alone.
Movers
of the Industry:
Key
players in the stereotactic system market include Alliance HealthCare
Services, Micromar Ind. e Com. LTDA, adeor Medical AG, Monteris
Medical, Elekta AB., and inomed Medizintechnik GmbH.
Stereotactic
Systems Market Taxonomy:
By
Equipment Type:
-
Gamma knife
-
Line accelerator (LINAC) machines
-
Proton beam
By
Applications:
-
Brain tumor
-
Arteriovenous malformations
-
Parkinson’s disease
-
Epilepsy
-
Breast Cancer
Request
For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2424
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment